| Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis |
45 |
| Assessment of Muscle Function and Physical Performance in Daily Clinical Practice: A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) |
39 |
| Prebiotics, Bone and Mineral Metabolism |
34 |
| Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women |
22 |
| Gut Microbiota, Immune System, and Bone |
17 |
| Biology of Bone Sarcomas and New Therapeutic Developments |
17 |
| Bone-Targeted Therapies in Cancer-Induced Bone Disease |
17 |
| Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome |
16 |
| Effects of Fermented Milk Products on Bone |
16 |
| Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications |
15 |
| Health Care Costs Associated With Muscle Weakness: A UK Population-Based Estimate |
15 |
| Differential Expression Profiles of Circular RNAs During Osteogenic Differentiation of Mouse Adipose-Derived Stromal Cells |
14 |
| Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates |
14 |
| Effects of Vitamin D3 Supplementation on Muscle Strength, Mass, and Physical Performance in Women with Vitamin D Insufficiency: A Randomized Placebo-Controlled Trial |
13 |
| Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period |
13 |
| Osteomimicry: How the Seed Grows in the Soil |
13 |
| Effects of High-Intensity Interval Running Versus Cycling on Sclerostin, and Markers of Bone Turnover and Oxidative Stress in Young Men |
12 |
| From Osteoimmunology to Osteomicrobiology: How the Microbiota and the Immune System Regulate Bone |
12 |
| Chronic Non-bacterial Osteomyelitis: A Review |
11 |
| Cancer Treatment and Bone Health |
10 |
| The Role of Osteoprotegerin in Vascular Calcification and Bone Metabolism: The Basis for Developing New Therapeutics |
10 |
| Relationships Between Markers of Inflammation and Muscle Mass, Strength and Function: Findings from the Hertfordshire Cohort Study |
10 |
| Glucocorticoids, Inflammation and Bone |
10 |
| Advances in Probiotic Regulation of Bone and Mineral Metabolism |
10 |
| Roles of Irisin in the Linkage from Muscle to Bone During Mechanical Unloading in Mice |
9 |
| Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review |
9 |
| Osteoporosis in Rheumatic Diseases: Anti-rheumatic Drugs and the Skeleton |
9 |
| Ultrastructure of Bone: Hierarchical Features from Nanometer to Micrometer Scale Revealed in Focused Ion Beam Sections in the TEM |
9 |
| Effects of Combined Whole-Body Electromyostimulation and Protein Supplementation on Local and Overall Muscle/Fat Distribution in Older Men with Sarcopenic Obesity: The Randomized Controlled Franconia Sarcopenic Obesity (FranSO) Study |
8 |
| Glycyrrhizin Suppresses RANKL-Induced Osteoclastogenesis and Oxidative Stress Through Inhibiting NF-kappa B and MAPK and Activating AMPK/Nrf2 |
8 |
| Hallmarks of Bone Metastasis |
8 |
| Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis |
8 |
| New agents in the Treatment of Myeloma Bone Disease |
8 |
| Alkaline Phosphatases in the Complex Chronic Kidney Disease-Mineral and Bone Disorders |
8 |
| MicroRNA-218 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells and Accelerates Bone Fracture Healing |
8 |
| Paget's Disease of Bone |
8 |
| Rare Inherited forms of Paget's Disease and Related Syndromes |
8 |
| Associations of Sarcopenia and Its Components with Bone Structure and Incident Falls in Swedish Older Adults |
8 |
| Long Noncoding RNA Analyses for Osteoporosis Risk in Caucasian Women |
8 |
| Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions |
7 |
| Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus |
7 |
| Overview of Osteoimmunology |
7 |
| Fibroblast Growth Factor (FGF) 23 Regulates the Plasma Levels of Parathyroid Hormone In Vivo Through the FGF Receptor in Normocalcemia, But Not in Hypocalcemia |
7 |
| Effect of Long-Term Green Tea Polyphenol Supplementation on Bone Architecture, Turnover, and Mechanical Properties in Middle-Aged Ovariectomized Rats |
7 |
| The Relationship Between Omega- Omega-6 and Total Polyunsaturated Fat and Musculoskeletal Health and Functional Status in Adults: A Systematic Review and Meta-analysis of RCTs |
7 |
| Coordination of Fusion and Trafficking of Pre-osteoclasts at the Marrow-Bone Interface |
7 |
| Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review |
7 |
| Associations Between Objectively Measured Physical Activity, Body Composition and Sarcopenia: Findings from the Hertfordshire Sarcopenia Study (HSS) |
7 |
| Bone Microstructure in Response to Vitamin D3 Supplementation: A Randomized Placebo-Controlled Trial |
7 |
| Abaloparatide Exerts Bone Anabolic Effects with Less Stimulation of Bone Resorption-Related Factors: A Comparison with Teriparatide |
6 |
